Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

@article{Carey2006RaceBC,
  title={Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.},
  author={Lisa Anne Carey and Charles M. Perou and Chad Livasy and Lynn G. Dressler and David W. Cowan and Kathleen Conway and Gamze F. Karaca and Melissa A. Troester and Chiu Kit Tse and Sharon N. Edmiston and Sandra L. Deming and Joseph Geradts and Maggie Chon U Cheang and Torsten O. Nielsen and Patricia G. Moorman and H. Shelton Earp and Robert C. Millikan},
  journal={JAMA},
  year={2006},
  volume={295 21},
  pages={
          2492-502
        }
}
CONTEXT Gene expression analysis has identified several breast cancer subtypes, including basal-like, human epidermal growth factor receptor-2 positive/estrogen receptor negative (HER2+/ER-), luminal A, and luminal B. OBJECTIVES To determine population-based distributions and clinical associations for breast cancer subtypes. DESIGN, SETTING, AND PARTICIPANTS Immunohistochemical surrogates for each subtype were applied to 496 incident cases of invasive breast cancer from the Carolina Breast… 

Figures and Tables from this paper

Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study

It is suggested that basal-like breast cancer is not an inherently more aggressive disease in African American women compared with whites, and that among women with luminal A breast cancer, African Americans have higher mortality than whites.

Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data.

The results indicate the importance of including molecular subtype, along with age, stage at diagnosis and comorbidity, in assessing breast cancer survival and highlight the need to address outcomes related to hormone-receptor-negative cancers, for which survival lags behind that for hormone- receptor-positive cancers.

Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and Survival

The single hormone receptor-positive subtypes, representing 10% of HER2− cancers, should be considered clinically distinct from ER+PR+ disease, with the ER−PR+ subtype having outcomes similar to those for ER− PR− cancers.

Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California

Hispanic women residing in low SES neighborhoods had significantly increased risk of developing and dying from HR− than HR+ breast cancers, indicating the need to better understand the impact of SES on risk factor exposures that increase the risk of breast cancer subtypes with poor prognosis.

Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.

The findings show that ERα methylation is correlated with poor prognosis subtypes of breast tumors in Iranian patients and may play an important role in pathogenesis of the more aggressive breast tumors.

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

The high prevalence of TNTs among younger women and particularly younger AA women, along with unique protein expression patterns and poorer survival, suggests varying gene–environment etiologies with respect to age and race/ethnicity and a need for effective therapies.

The epidemiology of triple-negative breast cancer, including race

Distinct breast cancer subtypes have unique sociodemographic, anthropometric and reproductive characteristics and possibly different pathways for development.

Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer

Obesity has divergent impacts on risk of aggressive subtypes of breast cancer in premenopausal versus postmenopausal women, which may contribute to the higher incidence rates of TN cancers observed among younger African American and Hispanic women.

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

A significant ethnic disparity in HER2-positive breast cancer in a large population-based cohort enriched for Asian-Americans is reported, which has implications for healthcare resource utilization, cancer biology, and clinical care.
...

References

SHOWING 1-10 OF 53 REFERENCES

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

A panel of four antibodies (ER, HER1, HER2, and cytokeratin 5/6) can accurately identify basal-like tumors using standard available clinical tools and shows high specificity.

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Germline BRCA1 mutations appear to be associated with a distinctive breast cancer phenotype, and the expression of cytokeratin 5/6 was statistically significantly associated with BRCa1-related breast cancers.

Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

Germline BRCA1 mutations appear to be associated with a distinctive breast cancer phenotype, and the expression of cytokeratin 5/6 was statistically significantly associated with BRCa1-related breast cancers.

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.

Hormone-related factors and family history of breast or ovarian cancer and medical radiation exposure to the chest produced higher odds ratios for ER-PR- than for ER+PR+ breast cancer, especially among pre-/perimenopausal women.

Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations

The results suggest that molecularly similar subtypes of breast cancer are indeed broadly conserved between Asian and Caucasian patients, and that these subtypes are already present at the preinvasive stage of carcinogenesis.

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

The results strongly support that among patients with familial breast cancer, those who have a BRCA1 mutation have a worse outcome than those who do not.

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  • C. SotiriouS. Neo E. Liu
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2003
Gene expression patterns were found to be strongly associated with estrogen receptor (ER) status and moderately associated with grade, but not associated with menopausal status, nodal status, or tumor size, in an unselected group of 99 node-negative and node-positive breast cancer patients.

"Intrinsic Gene Expression" subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestry.

  • O. OlopadeF. Ikpatt C. Perou
  • Medicine, Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2004
The majority of BCs from Nigeria are basal-like, which suggest a distinct pathogenesis probably involving genes in the BRCA1 pathway, and future work will evaluate components of this pathway to develop more effective targeted therapies.

Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.

Fluorescence in situ hybridization on formalin-fixed paraffin-embedded breast tumor tissue sections suggests that a germ-line mutation in the BRCA1 tumor suppressor gene is associated with a significantly lower level of HER-2/neu amplification.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.
...